34 completed, 12 unknown, 4 terminated, 4 withdrawn. 17 Not applicable, 9 Phase 2, 9 Phase 3, 4 Phase 1, 4 Phase 4.
Follow Hyperplasia: new trials by email Literature Review of Hyperplasia trials Research Report on Hyperplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer Tirzepatide - Endometrial Cancer, Endometrial Intraepithelial Neoplasia | Phase 2 | Not yet recruiting | UNC Lineberger Comprehensive Cancer Center | 40 | 2027-01-01 | 2026-09-28 |
| TREC - Evaluation of the Impact of Eversion Technical Features on the Rate of Carotid Restenosis This research does not require any specific investigation and does not imply any modification of treatment. - Hyperplasia | Unknown | University Hospital, Angers | 500 | 2024-03-01 | 2024-02-22 | |
| Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™ STRATICYTE™ Test - Mouth Diseases | Recruiting | Proteocyte Diagnostics Inc. | 180 | 2023-01-01 | 2024-11-07 | |
| ESWT on Human Gingival Fibroblasts extracorporeal shockwave device, Fibroblast cell lines not subjected to shockwaves from extracorporeal shockwave device - Periodontal Attachment Loss | Not applicable | Completed | Dr Prabhuji MLV | 20 | 2022-08-22 | 2023-03-13 |
| Extracorporeal Shock Wave Therapy on Osteoblast-Like Cells In- Vitro Study Extracorporeal shockwave device, No ESWT - Osteosarcoma | Not applicable | Completed | Krishnadevaraya College of Dental Sciences & Hospital | 20 | 2021-10-22 | 2023-04-06 |
| Thulium Fiber Laser Enucleation of the Prostate (TFLEP) vs HoLEP With Moses Technology (m-HoLEP) TFLEP, m-HoLEP - Benign Prostatic Hyperplasia | Not applicable | Unknown | Centre hospitalier de l'Université de Montréal (CHUM) | 100 | 2021-09-08 | 2023-10-26 |
| Establishment and Application of 3-Dimensional (3-D) Cell Culture Model of Clinical Circulating Tumor Cells (CTCs) CTCs isolation/purification and cell number expansion - Cell Carcinoma | Completed | Chang Gung Memorial Hospital | 160 | 2021-08-31 | 2025-09-24 | |
| Cementation Techniques; an In-vitro Study Cementation Technique A, Cementation Technique B, Cementation Technique C - Cementation Teeth; Hyperplasia, Dental Cements | Not applicable | Completed | Ziauddin University | 120 | 2019-01-06 | 2023-05-25 |
| Subcutaneous Hydrocortisone Children With Congenital Adrenal Hyperplasia Subcutaneous hydrocortisone - Congenital Adrenal Hyperplasia, Hyperplasia | Phase 1 | Completed | University of Minnesota | 11 | 2019-01-01 | 2025-06-25 |
| Effects of Avmacol® in the Oral Mucosa of Patients Following Curative Treatment for Tobacco-related Head and Neck Cancer Avmacol - Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC) | Not applicable | Completed | University of Pittsburgh | 6 | 2018-07-27 | 2023-04-07 |
| Ultrasound Assisted Wound Debridement (UAW) Versus Standard Wound Treatment in Complicated Diabetic Foot Ulcers (DFU) Ultrasound group, Surgical group - Diabetic Foot Ulcer | Not applicable | Completed | Universidad Complutense de Madrid | 51 | 2017-11-01 | 2021-07-14 |
| Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer Avmacol® - HNSCC, Head and Neck Cancer | Early Phase 1 | Completed | University of Arizona | 6 | 2017-04-24 | 2021-06-21 |
| Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion Laboratory Biomarker Analysis, Metformin Hydrochloride - Erythroplakia, Hyperplasia | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 26 | 2016-06-10 | 2026-06-26 |
| Castleman Disease Collaborative Network Biobank Sample Collection - Castleman Disease, Castleman's Disease | Withdrawn | Castleman Disease Collaborative Network | 2016-06-01 | 2018-07-31 | ||
| Unlock the Cell: Castleman's Disease Flow Cytometry Study Blood draw/buccal swab - Castleman Disease, Angiofollicular Lymphoid Hyperplasia | Completed | University of Pennsylvania | 130 | 2016-02-01 | 2020-03-26 | |
| Adipose Tissue Expandability and Type 2 Diabetes Type2 Diabetes Mellitus | Completed | Charles University, Czech Republic | 44 | 2016-01-01 | 2020-02-13 | |
| Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia Embozene Microspheres - Prostatic Hyperplasia, Benign Prostatic Hyperplasia (BPH) | Not applicable | Unknown | University of Virginia | 50 | 2015-11-01 | 2019-04-17 |
| Study Into Treatment of Hyperplasia of Mammary Glands No intervention - Hyperplasia | Unknown | Shandong University | 5000 | 2015-04-01 | 2015-07-22 | |
| Early Prediction of Oral Cancer by S100A7 Immunohistochemistry Signature-based Assessment Standard of Care Histopathology, STRATICYTE Assessment - Oral Neoplasm | Recruiting | Proteocyte Diagnostics Inc. | 500 | 2015-03-12 | 2024-11-07 | |
| Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life EPA, Placebo - Prostate Cancer | Phase 2 | Active not recruiting | CHU de Quebec-Universite Laval | 130 | 2015-02-12 | 2026-10-23 |
Showing 20 of 59. Sign in to see all of them.
Prostatic Hyperplasia (10) · Breast Neoplasms (5) · Lower Urinary Tract Symptoms (5) · Head and Neck Neoplasms (4) · Erythroplasia (3) · Genital Diseases, Male (3) · Pathologic Processes (3) · Prostatic Diseases (3) · Squamous Cell Carcinoma of Head and Neck (3) · Adrenal Gland Diseases (2) · Adrenal Hyperplasia, Congenital (2) · Adrenocortical Hyperfunction (2) · Carcinoma in Situ (2) · Carcinoma, Non-Small-Cell Lung (2)
Pathological Conditions, Signs and Symptoms (59) · Pathologic Processes (56) · Neoplasms (21) · Urogenital Diseases (19) · Neoplasms by Site (17) · Genital Diseases (15) · Male Urogenital Diseases (14) · Neoplasms by Histologic Type (11) · Genital Diseases, Male (9) · Prostatic Diseases (9) · Skin Diseases (8) · Skin and Connective Tissue Diseases (8) · Female Urogenital Diseases and Pregnancy Complications (7) · Neoplasms, Glandular and Epithelial (7) · Pathological Conditions, Anatomical (7)
Eicosapentaenoic Acid (2) · Endoscopy (2) · Anesthesia, Spinal (1) · Angioplasty (1) · Blood Specimen Collection (1) · Calcitriol (1) · Cholecalciferol (1) · Clinical Chemistry Tests (1) · Colonoscopy (1) · Cystoscopy (1) · Dutasteride (1) · Electrocoagulation (1) · Metformin (1) · Microspheres (1) · NBI 77860 (1)
National Cancer Institute (NCI) (4) · Anesiva, Inc. (2) · Mansoura University (2) · National Taiwan University Hospital (2) · Proteocyte Diagnostics Inc. (2) · S.L.A. Pharma AG (2) · Shandong University (2) · Angiotech Pharmaceuticals (1) · Apsen Farmaceutica S.A. (1) · Asker & Baerum Hospital (1) · Atossa Therapeutics, Inc. (1) · Bayer (1) · Boston Scientific Corporation (1) · CHU de Quebec-Universite Laval (1) · Carol Fabian, MD (1)
United States (27) · Canada (6) · Taiwan (3) · Brazil (2) · China (2) · Egypt (2) · Germany (2) · India (2) · Italy (2) · United Kingdom (2) · Argentina (1) · Austria (1) · Czechia (1) · France (1) · Hong Kong (1)
Ahmed M Elshal, MD (2) · Nicholas J West, MB BS FRCS (2) · Alan Cantor, PhD (1) · Ari Isaacson, MD (1) · Carol Fabian, MD (1) · Carolyn L Kerrigan, MD (1) · Clare C Sun, M.D. (1) · Claus Roehrborn, MD (1) · Dan P Zandberg, MD (1) · David C Fajgenbaum, MD, MBA, MSc (1) · Dr. Susan Love, MD (1) · Eduardo Carneiro de Lyra, MD, PhD (1) · Elisabet Andersson (1)
PMID 15893169, PMID 18082503, PMID 18307999, PMID 18360849, PMID 19737719, PMID 20348368, PMID 21497839, PMID 21741692, PMID 21871706, PMID 21954478, PMID 23083656, PMID 26299520, PMID 28341525, PMID 29321047, PMID 31831295, PMID 33278125, PMID 33658980, PMID 34255745, PMID 37787025, PMID 38353936, PMID 38519581, PMID 41054469
2004 (1), 2008 (1), N01CN00031 (1), P30CA023074 (1), P50CA097190 (1), U01CA281026 (1), U01DK063788 (1)